Scarica l'app Stockscreener
67.01
2.41%
1.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CYTK Giù?
Forum
Previsione
Frazionamento azionario
Cytokinetics Inc Borsa (CYTK) Ultime notizie
Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire
Cytokinetics, Incorporated $CYTK Shares Acquired by Commonwealth of Pennsylvania Public School Empls Retrmt SYS - Defense World
Cytokinetics Shares Face Critical FDA Verdict - Ad-hoc-news.de
Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Ready to Jump After Recent Trade: Cytokinetics Inc (CYTK) - Setenews
Rep. Gilbert Ray Cisneros, Jr. Buys Cytokinetics, Incorporated (NASDAQ:CYTK) Stock - Defense World
How Cytokinetics Incorporated (KK3A) stock trades under stagflationWeekly Gains Report & Safe Capital Growth Trade Ideas - newser.com
What macro factors could drive Cytokinetics Incorporated (KK3A) stock higherJuly 2025 Action & Weekly Watchlist for Hot Stocks - newser.com
Insider Sell: B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Is Cytokinetics Incorporated (KK3A) stock trading at attractive multiplesJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
[Form 4] CYTOKINETICS INC Insider Trading Activity - Stock Titan
Cytokinetics Director Sells 5,000 Shares - TradingView
Dir Parshall Sells 5,000 ($323.7K) Of Cytokinetics Inc [CYTK] - TradingView
What market sentiment indicators show for Cytokinetics Incorporated (KK3A) stock2025 Institutional Moves & High Yield Stock Recommendations - newser.com
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea ... - Bluefield Daily Telegraph
Will Cytokinetics Incorporated (KK3A) stock draw ESG focused funds - newser.com
Cytokinetics Inc (KK3A.HM) Stock Historical Prices & Data - Yahoo! Finance Canada
Cytokinetics Inc (KK3A.HM) Latest Stock News & Headlines - Yahoo! Finance Canada
Cytokinetics Inc (KK3A.HM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Insider Sell Alert: Fady Malik Sells 2,200 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Cytokinetics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Cytokinetics Executive Sells Shares - TradingView
Cytokinetics Grants Stock Options and RSUs to New Executive and Employees as Inducements to Employment - Quiver Quantitative
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
CYTK Deadline: CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
What Does the Market Think About Cytokinetics Inc? - Benzinga
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); enCore Energy ... - Bluefield Daily Telegraph
Lost Money on Cytokinetics, Incorporated (CYTK)? Urged to Join Class Action Before November 17, 2025 – Contact Levi & Korsinsky - ACCESS Newswire
Cytokinetics Incorporated (CYTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Urgently Reminds Investors of - GlobeNewswire
Total debt per share of Cytokinetics, Incorporated – DUS:KK3A - TradingView
Recover Investment Losses: Class Action Initiated Against Cytokinetics, Incorporated (CYTK) - ACCESS Newswire
Cytokinetics at Jefferies London: Aficamten’s Strategic Path Forward By Investing.com - Investing.com Canada
Cytokinetics at Jefferies London: Aficamten’s Strategic Path Forward - Investing.com India
CYTK FINAL DEADLINE: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit - Business Wire
Cytokinetics at Jefferies London: Aficamten's Strategic Path Forward - Investing.com
Cytokinetics at Jefferies London: Aficamten's Strategic Path Forward By Investing.com - Investing.com Nigeria
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated Investors - GlobeNewswire
Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) InvestorsContact Levi & Korsinsky Before November 17, 2025 - ACCESS Newswire
Former Exelixis GC Named Legal Chief At Cytokinetics - Law360
Cytokinetics (CYTK) Supports American Heart Association Initiati - GuruFocus
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders - MarketScreener
Cytokinetics supports American Heart Association initiative to improve care for people living with hypertrophic cardiomyopathy - MarketScreener
Cytokinetics Supports American Heart Association Initiative to Enhance Care for Hypertrophic Cardiomyopathy Patients - Quiver Quantitative
Cytokinetics (Nasdaq: CYTK) backs AHA effort to expand HCM registry, reduce underdiagnosis - Stock Titan
Cytokinetics Shares Surge Amid Legal Challenges and Clinical Promise - Ad-hoc-news.de
Imbria Pharmaceuticals, Inc. announced that it has received funding from a group of investors - MarketScreener
Cytokinetics 24 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Cytokinetics, IncorporatedCYTK - Louisiana First News
November 17, 2025 Deadline: Join Class Action Lawsuit Against Cytokinetics, Incorporated (CYTK)Contact Levi & Korsinsky - ACCESS Newswire
Key facts: Cytokinetics stock drops 12.98%; class action lawsuit filed - TradingView
Can Cytokinetics Incorporated (KK3A) stock deliver double digit returnsWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
CTYK DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Cytokinetics, Incorporated Investors to Join the Class Action Lawsuit - ACCESS Newswire
Cytokinetics Incorporated recovery potential after sell offFed Meeting & Daily Market Momentum Tracking - newser.com
Levi & Korsinsky Urges Cytokinetics, Incorporated (CYTK) Shareholders to Act Before Lead Plaintiff Deadline November 17, 2025 - ACCESS Newswire
CYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages - GlobeNewswire
Cytokinetics Inc (KK3A.MU) stock price, news, quote and history - Yahoo Finance Singapore
Cytokinetics 48 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Cytokinetics, IncorporatedCYTK - Louisiana First News
Key facts: Cytokinetics appoints new EVP; stock drops 20.34% amid FDA delay - TradingView
Cytokinetics appoints Jeffrey J. Hessekiel as EVP and chief legal officer - Investing.com Australia
1.18%
5.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):